Publication | Closed Access

Effects of combined angiotensin II receptor antagonism and neprilysin inhibition in experimental pulmonary hypertension and right ventricular failure

HypertensionHeart FailureNeprilysin InhibitionPulmonary Arterial HypertensionCardiovascular DiseasePulmonary CirculationMedicinePhysiologyExperimental Pulmonary HypertensionCardiovascular PharmacologyPulmonary HypertensionPublic HealthPharmacologyCardiologyRight Ventricular FailureDiastolic FunctionPulmonary Vascular Disease